Therapeutic Hemp Medical Access Act of 2017
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 2, 2017
Read twice and referred to the Committee on the Judiciary.
May 2, 2017
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Therapeutic Hemp Medical Access Act of 2017
This bill amends the Controlled Substances Act (CSA):
- to add definitions for the terms "cannabidiol," "cannabidiol-rich plants," and "tetrahydrocannabinol concentration";
- to exclude cannabidiol and cannabidiol-rich plants from the definition of marijuana; and
- to remove cannabidiol and cannabidiol-rich plants from coverage under the CSA.
It also specifies that no provision of this bill prohibits or restricts the use, production, or distribution of marijuana in a state in which such activities are legal under state law.
What's happening now
Read twice and referred to the Committee on the Judiciary.
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 1008: Therapeutic Hemp Medical Access Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-S-1008/
"S. 1008: Therapeutic Hemp Medical Access Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-1008/.
S. 1008, 115th Cong. (2026), https://openamerica.io/bill/115-S-1008/.
[S. 1008: Therapeutic Hemp Medical Access Act of 2017](https://openamerica.io/bill/115-S-1008/)